Pulmonary delivery of nanomedicines is very promising in lung local disease treatments
whereas several physiological barriers limit its application via the interaction with inhaled …

Various nanoparticles are used in the discovery of new nanomedicine to overcome the
shortages of conventional drugs. Therefore, this article presents a comprehensive and up-to …

Pulmonary administration of biodegradable polymeric formulation is beneficial in the
treatment of various respiratory diseases. For respiratory delivery, the polymer must be non …

It is reported that pulmonary fibrosis has become one of the major long-term complications of
COVID-19, even in asymptomatic individuals. Currently, despite the best efforts of the global …

With the great success of coronavirus disease (COVID-19) messenger ribonucleic acid
(mRNA) vaccines, mRNA therapeutics have gained significant momentum for the prevention …

Background Non-small cell lung cancer (NSCLC) is a worldwide health threat with high
annual morbidity and mortality. Chemotherapeutic drugs such as paclitaxel (PTX) have been …

Antibody–drug conjugates (ADCs) comprise antibodies, cytotoxic payloads, and linkers,
which can integrate the advantages of antibodies and small molecule drugs to achieve …

Despite advancements in the medical and pharmaceutical fields, tuberculosis remains a
major health problem globally. Patients do not widely accept the conventional approach to …

Over the past several decades, liposomes have been extensively developed and used for
various clinical applications such as in pharmaceutical, cosmetic, and dietetic fields, due to …

Exposure of inhaled nanoparticles (NPs) to the deep lung tissue results in the adsorption of
pulmonary surfactant (PSf) on the surface of NPs and the formation of a biomolecular …